Ecstasy used to treat war veterans in new research

866108-steve-mcdonald

A WAR veteran is fighting for a party drug to be legalised for medical use, after US research found it may be able to treat post-traumatic stress disorder (PTSD).

The research, published in the Journal of Psychopharmacology this month, has found that PTSD sufferers who took ecstasy (MDMA) in a supervised session once a month experienced a long-term recovery from symptoms.

Nearly 90 per cent of patients reported an improvement in their general wellbeing three-and-a-half years after treatment, which included taking MDMA in comfortable sessions, and 68 per cent reported fewer flashbacks, nightmares and intrusive memories.
This came after conventional treatments for the disorder, counselling and anti-depressants had failed the patients.

Read more here: http://www.news.com.au/lifestyle/health/party-drug-to-treat-war-veterans/story-fneuz9ev-1226524911310

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.

PRISM

We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.

Newsletter

Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search